Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP470906.RAd1s2F74HVcDJK444CXrCUYatAL3Pe6Y8wP_goNarMx4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP470906.RAd1s2F74HVcDJK444CXrCUYatAL3Pe6Y8wP_goNarMx4130_assertion type Assertion NP470906.RAd1s2F74HVcDJK444CXrCUYatAL3Pe6Y8wP_goNarMx4130_head.
- NP470906.RAd1s2F74HVcDJK444CXrCUYatAL3Pe6Y8wP_goNarMx4130_assertion description "[For stand-alone therapy for enhancing cognition, 5-HT(1A) partial agonists, 5-HT(2A) antagonists, 5-HT(4) partial agonists and 5-HT(6) antagonists are all likely to induce at least modest improvement in cognition in schizophrenia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP470906.RAd1s2F74HVcDJK444CXrCUYatAL3Pe6Y8wP_goNarMx4130_provenance.
- NP470906.RAd1s2F74HVcDJK444CXrCUYatAL3Pe6Y8wP_goNarMx4130_assertion evidence source_evidence_literature NP470906.RAd1s2F74HVcDJK444CXrCUYatAL3Pe6Y8wP_goNarMx4130_provenance.
- NP470906.RAd1s2F74HVcDJK444CXrCUYatAL3Pe6Y8wP_goNarMx4130_assertion SIO_000772 15205874 NP470906.RAd1s2F74HVcDJK444CXrCUYatAL3Pe6Y8wP_goNarMx4130_provenance.
- NP470906.RAd1s2F74HVcDJK444CXrCUYatAL3Pe6Y8wP_goNarMx4130_assertion wasDerivedFrom befree-20150227 NP470906.RAd1s2F74HVcDJK444CXrCUYatAL3Pe6Y8wP_goNarMx4130_provenance.
- NP470906.RAd1s2F74HVcDJK444CXrCUYatAL3Pe6Y8wP_goNarMx4130_assertion wasGeneratedBy ECO_0000203 NP470906.RAd1s2F74HVcDJK444CXrCUYatAL3Pe6Y8wP_goNarMx4130_provenance.